HOME ·

03696.HK

INSILICO (03696.HK): Enters CNS Drug R&D Collaboration with Cosmo Pharmaceutical, Potential Milestone Payments Up to Approximately RMB1.2 Billion
Tags：
Insilico03696.HKCMS00867.HKDrug Collaboration
2026-07-13
InSilico Medicine (03696.HK): Expects to Turn Profit in H1, Net Profit of US$33.5M to US$39.5M
Tags：
Insilico03696.HK
2026-07-09
INSILICO(03696.HK): Phase III Clinical Trial of Rentosertib for Idiopathic Pulmonary Fibrosis Officially Launched
Tags：
Insilico03696.HKClinical Trial
2026-07-08
Insilico Medicine (03696.HK): Strategic Partnership with Takeda for AI-Driven Drug Discovery with Total Value Up to USD 600 Million
Tags：
Insilico Medicine03696.HK
2026-07-02
Insilico Medicine (03696.HK): Two Core Senior Executives Voluntarily Extend Lock-up Period to June 2027
Tags：
Insilico Medicine03696.HK
2026-06-30
INSILICO(03696.HK) Enters AI-Powered R&D Collaboration with SK Biopharmaceuticals, Total Potential Deal Value Exceeds USD2.5 Billion
Tags：
Insilico03696.HKResearch and Development Collaboration
2026-06-22
INSILICO(03696.HK) closed 10.1% higher
Tags：
Insilico03696.HK
2026-04-22
INSILICO(03696.HK) closed 14.06% higher, The full-day turnover stood at HKD 618.6 million
Tags：
Insilico03696.HK
2026-04-20
InSilico Medicine (03696.HK) Inks AI Drug Discovery Deal Exceeding HK$931 Million Including Sales Milestones
Tags：
Insilico03696.HKAI
2026-01-27
InSilico (03696.HK): Partnering with Servier on an $888 Million AI-Driven Anti-Tumor Innovative Drug Initiative
Tags：
Insilico03696.HKInnovative Drugs
2026-01-05